by John Conrad | Dec 3, 2020 | Community News
Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announced it has established its U.S. headquarters in Chicago, today announced it has...
by John Conrad | Nov 11, 2020 | Community News
3D-Printed Implants that Repair Tissues and Organs Moving Towards FDA Approval CHICAGO, Illinois, USA – November 10, 2020 – Dimension Inx, a next-generation biofabrication company developing regenerative medical implants that repair tissues and organs, announced that...
by John Conrad | Jun 3, 2020 | Community News
Pfizer Breakthrough Growth Initiative will invest up to $500 million across a portfolio of clinical-stage biotechnology companies Pfizer Inc. (NYSE: PFE) announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to...
by John Conrad | Apr 23, 2020 | Community News, COVID
As the COVID-19 crisis continues to unfold, Takeda’s Patient Assistance Response team is working around the clock to help ensure that the people who need our medicines and treatments can continue to access them safely and without interruption. Consistent with our...
by John Conrad | Apr 6, 2020 | Community News, COVID
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19 Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and...
by John Conrad | Mar 31, 2020 | Community News, COVID
BioLife Plasma Services, part of Takeda, has implemented a unique protocol for collecting plasma from healthy individuals who have recovered from COVID-19 to enable development of a potential therapy for COVID-19, made from human plasma. You can read more about this...
